semaglutide ckd approval Poll: Do you think we'll see new FDA for semaglutide, specifically or Heart Failure and/or CKD, in 2025? 💊 This post highlights primary takeaways from 2 major trials from the past ~ Semaglutide could be 'practice changing'

Scheiblich H, Eikens F, Wischhof L, Opitz S, Jngling K, Cserp C, Schmidt SV, Lambertz J, et al

Daz-Manera, J., Urtizberea, J

Access to manufacturer savings and copay facilitation options further amplify affordability

MC4R is predominantly localized within the hypothalamic regions of the central nervous system and is speculated to modulate energy homeostasis and neurobehavioral functions

Clinical Indicators for Switching: Response, Tolerance, and Efficacy Profiles Healthcare providers consider several factors when evaluating whether a switch is appropriate: inadequate weight loss response at maximum tolerated dose, gastrointestinal side effects that limit dose escalation, or a need for enhanced metabolic impact

This raises questions around how cannabis could play a role in combating the negative health effects of obesity